← Leaderboards
Thuy Le
Duke University
$9,408,752
Attributed
$10,707,163
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,707,163 · 7
By mechanism
R01$7,591,739 · 3
U01$1,855,783 · 1
R21$876,350 · 2
P30$383,291 · 1
Top collaborators
- Ashutosh Chilkoti4 shared
- Joseph Heitman2 shared
Others in their field
Other Emerging Leaders on “Southeastern Asia”
- Jeongmin Song · Cornell University$7,854,089
- Anavaj Sakuntabhai · Institut Pasteur$4,856,970
- Benjamin J Burwitz · Oregon Health & Science University$3,842,980
- Paul John Norman · University Of Colorado Denver$3,096,352
- Evan Newell · Fred Hutchinson Cancer Research Center$2,763,230
- Gerhard Walzl · Stellenbosch University$2,353,038
Research focus
Southeastern AsiaTalaromycesFungusCessation Of LifeMortalityAcquired Immunodeficiency SyndromeCohortBurden Of IllnessBloodDiagnosisVietnamCountrySamplingChinaDiagnosticPatient-Focused OutcomesInfectionUrinePersonsScreeningDetectionAmphotericin BAsiaItraconazole
Grant awards (23)
Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST)$750,131
R01 · FY2025 · AI · contact PI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$556,460
R01 · FY2025 · AI · contact PI
Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST)$531,188
R01 · FY2025 · AI · contact PI
Clinical Core$383,291
P30 · FY2025 · AI · contact PI
Tropical Medicine Research Center for Talaromycosis in Vietnam$328,388
U01 · FY2025 · AI · contact PI
Tropical Medicine Research Center for Talaromycosis in Vietnam$235,391
U01 · FY2025 · AI · contact PI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$138,564
R01 · FY2025 · AI · contact PI
Tropical Medicine Research Center for Talaromycosis in Vietnam$97,011
U01 · FY2025 · AI · contact PI
Liposomal Amphotericin B and Flucytosine Antifungal Strategies for Talaromycosis (LAmB-FAST)$1,326,630
R01 · FY2024 · AI · contact PI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$726,999
R01 · FY2024 · AI · contact PI
Making an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV disease in Southeast Asia$489,183
R01 · FY2024 · AI · contact PI
Tropical Medicine Research Center for Talaromycosis in Vietnam$167,028
U01 · FY2024 · AI · contact PI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid$732,049
R01 · FY2023 · AI · contact PI
Making an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV disease in Southeast Asia$569,682
R01 · FY2023 · AI · contact PI
Tropical Medicine Research Center for Talaromycosis in Vietnam$498,960
U01 · FY2023 · AI · contact PI
Tropical Medicine Research Center for Talaromycosis in Vietnam$529,005
U01 · FY2022 · AI · contact PI
Implications of mycoviral infection in Talaromyces marneffei: an analysis of human patient samples, RNAi, and hypermutation$241,500
R21 · FY2022 · AI
Mapping of the IgM and IgG antibody responses to Talaromyces marneffei infection in mice and humans - Deciphering acute from reactivated or latent infections$201,250
R21 · FY2022 · AI · contact PI
Making an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV disease in Southeast Asia$594,989
R01 · FY2021 · AI · contact PI
Mapping of the IgM and IgG antibody responses to Talaromyces marneffei infection in mice and humans - Deciphering acute from reactivated or latent infections$232,350
R21 · FY2021 · AI · contact PI
Implications of mycoviral infection in Talaromyces marneffei: an analysis of human patient samples, RNAi, and hypermutation$201,250
R21 · FY2021 · AI
Making an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV disease in Southeast Asia$594,989
R01 · FY2020 · AI · contact PI
Making an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV disease in Southeast Asia$580,875
R01 · FY2019 · AI · contact PI